Risks of cholesterol-lowering therapies [3]

Biological Psychiatry

Volumn 40, Issue 7, 1996, Pages 686-687

  Hibbeln, J R ^a   Salem N , Jr ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FATTY ACID; FENFLURAMINE; HYPOCHOLESTEROLEMIC AGENT;

DIET; HUMAN; LETTER; MORTALITY; PRIORITY JOURNAL; SUICIDE;

EID: 0029957408     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(96)00173-4     Document Type: Letter

References (7)

1. Agheli N Jacotot B Effect of simvastatin and fenofibrate on the fatty acid composition of hypercholesterolaemic patients Br J Pharm 4 1991 423 428
2. Delva NJ Mathews DR Cowen PJ Brain serotonin (5-HT) neuroendocrine function in patients taking cholesterol lowering drugs Biol Psychiatry 39 1996 100 106
3. Grønn M Christensen E Hagve T Christophersen BO Effects of clofibrate feeding on desaturation and oxidation in isolated rat liver cells BBA 1123 1992 170 176
4. Hibbeln JR Salem N Jr Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy Am J Clin Nutr 62 1995 1 9
5. Mitchell DC Kibelbek J Litman BJ Rhodopsin in dimyristoylphosphatidyl-choline-reconstituted bilayers forms metarhodopsin II and activates Gt Biochem 30 1 1991 37 42
6. Salem N Jr Kim HY Yergey JA Docosahexaenoic acid: membrane function and metabolism Simopoulos A Kifer RR Martin R Health Effects of Polyunsaturated Seafoods 15 1986 Academic Press New York 263 317
7. Strandberg TE Raikkonen K Partinen M Pihl S Vanhanen H Miettinen TA Associations of cholesterol lowering by statins with anger and hostility in hypercholesterolemic men Biol Psychiatry 35 1994 575 577